{"date":"2026-08-28","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6620-2026-08-28-2044-z99q86","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"20:44:02","subject":"公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC 505(b)(2)新藥HND-039 Omcazio美國專利侵權訴訟已由原告自行撤回訴訟","clause":"第2款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-08-28 20:44，「公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC 505(b)(2)新藥H」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-08-28-2008-11rykjr","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-08-28","time":"20:08:57","subject":"本公司用於治療 HER2 陽性乳癌之抗體藥物複合體生物相似藥 TSY-110，已向歐洲法規機構遞交臨床試驗申請","clause":"第10款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-08-28 20:08，「本公司用於治療 HER2 陽性乳癌之抗體藥物複合體生物相似藥 TSY-110，已向歐洲法規機構遞交臨床試驗申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-08-28-1928-1yzl4fj","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"19:28:45","subject":"代重要子公司欣德芮(股)公司公告召開115年股東臨時會","clause":"第17款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-08-28 19:28，「代重要子公司欣德芮(股)公司公告召開115年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-08-28-1829-l0uvpa","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"18:29:14","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-08-28 18:29，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-28-1721-krj11r","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-28","time":"17:21:52","subject":"本公司新藥CBL-514注射劑樞紐三期臨床試驗CBL-0301向美國FDA提出試驗變更案已通過FDA IND 30天審閱期。","clause":"第10款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-28 17:21，「本公司新藥CBL-514注射劑樞紐三期臨床試驗CBL-0301向美國FDA提出試驗變更案已通過FDA IND 30天審閱」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-08-28-1703-1xdaiqw","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"17:03:07","subject":"公告本公司第15次庫藏股買回執行情形","clause":"第35款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-08-28 17:03，「公告本公司第15次庫藏股買回執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-08-28-1543-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"15:43:00","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」阿拉伯聯合大公國專利核准通知書。","clause":"第53款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-08-28 15:43，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-28-1534-vxh4e5","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-28","time":"15:34:08","subject":"公告本公司處分有價證券","clause":"第20款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-28 15:34，「公告本公司處分有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-28-1527-1nmtgb","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"15:27:35","subject":"補公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-18","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-28 15:27，「補公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-08-28-1521-1nsksc0","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-08-28","time":"15:21:13","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2026-08-28","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-08-28 15:21，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-08-28-1446-61p5oe","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-08-28","time":"14:46:42","subject":"本公司受邀參加統一證券舉辦之投資論壇","clause":"第12款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-08-28 14:46，「本公司受邀參加統一證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-28-1410-1pkgjor","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-28","time":"14:10:23","subject":"本公司受邀參加元大證券舉辦之中文法人說明會，將就本公司財務及營運狀況向投資法人說明","clause":"第12款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-28 14:10，「本公司受邀參加元大證券舉辦之中文法人說明會，將就本公司財務及營運狀況向投資法人說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}